These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 10703934

  • 1. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [Abstract] [Full Text] [Related]

  • 2. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213
    [Abstract] [Full Text] [Related]

  • 3. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MI, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S.
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [Abstract] [Full Text] [Related]

  • 4. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [Abstract] [Full Text] [Related]

  • 5. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Feb; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 6. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
    MacDonald HM, McGuigan FA, New SA, Campbell MK, Golden MH, Ralston SH, Reid DM.
    J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.
    Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR.
    Ren Fail; 2005 Sep; 27(2):155-61. PubMed ID: 15807179
    [Abstract] [Full Text] [Related]

  • 8. [Study on the relationship between some genetic factors and peak bone mineral density in Beijing young women].
    Yang X, Zheng SR, Chen RJ, Chen SL, Fan ZH, Li H, Lu YH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):273-6. PubMed ID: 12895309
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB, Gallagher JC, Knezetic JA, Haynatzka V.
    Maturitas; 2006 Mar 20; 53(4):371-9. PubMed ID: 16139450
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
    Albagha OM, McGuigan FE, Reid DM, Ralston SH.
    J Bone Miner Res; 2001 Jan 20; 16(1):128-34. PubMed ID: 11149476
    [Abstract] [Full Text] [Related]

  • 11. [Relationship between estrogen receptor genotypes and female bone mineral density].
    Zhang Q, Yang D, Kuang J.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jun 20; 36(6):344-7. PubMed ID: 11783132
    [Abstract] [Full Text] [Related]

  • 12. [Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women].
    Dong J, Huang ZW, Piao JH, Gong J.
    Wei Sheng Yan Jiu; 2006 Mar 20; 35(2):196-200. PubMed ID: 16758971
    [Abstract] [Full Text] [Related]

  • 13. Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Partanen J, Mäenpää PH.
    Ann Med; 2002 Mar 20; 34(1):64-72. PubMed ID: 12014437
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women.
    Liu J, Zhu H, Zhu X, Dai M, Jiang L, Xu M, Chen J.
    Chin Med J (Engl); 2003 Mar 20; 116(3):364-7. PubMed ID: 12781038
    [Abstract] [Full Text] [Related]

  • 15. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F, JPOS Study Group.
    Int J Epidemiol; 2004 Oct 20; 33(5):979-88. PubMed ID: 15358739
    [Abstract] [Full Text] [Related]

  • 16. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women.
    Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, Michiels L, Cassiman JJ, Boonen S, Raus J, Geusens P.
    J Bone Miner Res; 1999 Sep 20; 14(9):1576-82. PubMed ID: 10469287
    [Abstract] [Full Text] [Related]

  • 17. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
    Sirola J, Kröger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S.
    Osteoporos Int; 2003 Jan 20; 14(1):27-33. PubMed ID: 12577182
    [Abstract] [Full Text] [Related]

  • 18. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
    Komulainen M, Kröger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R, Jurvelin J, Saarikoski S.
    J Clin Endocrinol Metab; 1999 Feb 20; 84(2):546-52. PubMed ID: 10022414
    [Abstract] [Full Text] [Related]

  • 19. Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density.
    Kurabayashi T, Matsushita H, Tomita M, Kato N, Kikuchi M, Nagata H, Honda A, Yahata T, Tanaka K.
    J Bone Miner Metab; 2004 Feb 20; 22(3):241-7. PubMed ID: 15108066
    [Abstract] [Full Text] [Related]

  • 20. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S.
    Osteoporos Int; 1998 Feb 20; 8(1):32-8. PubMed ID: 9692075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.